Knicks’ Bench Boost: Pacôme Dadiet’s Emergence Signals a Promising Trend
The Fresh York Knicks are finding success beyond their starting lineup, and a recent game against the Denver Nuggets highlighted the growing impact of their bench depth. A 20-year-old Frenchman reminded everyone why the Knicks have been patient with his development.
Dadiet’s Breakout Performance Against the Nuggets
With the Knicks comfortably ahead against the Nuggets on March 6, 2026, Pacôme Dadiet entered the game at 9:03 of the final quarter. He quickly made an impact, scoring 11 points in just nine minutes of play. Dadiet shot 4-of-5 from the field, including 3-for-3 from beyond the arc, and added an offensive and defensive rebound, finishing with a +13 plus/minus.
Pacome Blowout Comb Dadiet in 8 minutes off the bench:
11 points career high
4-5 FG
3-3 three
+13pic.twitter.com/ye8hk928xZ— New York Basketball (@NBA_NewYork) March 7, 2026
Coach Brown’s Vision for Young Talent
Head coach Mike Brown has emphasized the importance of developing young players like Dadiet. “He’s been playing well in the G League, been shooting a mess out of it. He’s got great size and we just want – he’s young, Mo’s young – and we want those guys to keep growing and developing,” Brown said. He believes that seeing success in NBA games boosts confidence not only for the players themselves but too for the entire team.
The Competition on the Wing: Dadiet and Diawara
Dadiet’s performance came as a contrast to recent attention surrounding Mohamed Diawara, who had been gaining momentum with a strong performance against the Spurs earlier in the month. While Diawara had a +25 game against Milwaukee, he was held to just four points in 13 minutes against the Nuggets. Dadiet’s emergence doesn’t overshadow Diawara’s progress; instead, it creates healthy competition for minutes, potentially strengthening the Knicks’ overall performance.
Pro Tip:
Developing a deep bench is crucial for sustained success in the NBA. It allows teams to rest starters, adapt to different matchups, and maintain a high level of play throughout the season.
What So for the Knicks’ Future
The Knicks’ ability to identify and nurture young talent is becoming a key strength. Dadiet’s performance, while in garbage time, demonstrated his potential and provided a glimpse of what he can bring to the team. This, combined with the continued development of players like Diawara, suggests a bright future for the Knicks’ bench.
FAQ
Q: How many points did Pacôme Dadiet score against the Nuggets?
A: He scored 11 points.
Q: What was Dadiet’s shooting percentage in that game?
A: He shot 4-of-5 from the field and 3-for-3 from three-point range.
Q: What does Coach Brown say about Dadiet’s development?
A: He emphasizes Dadiet’s progress in the G League and the importance of continued growth for young players.
Q: Who is Mohamed Diawara?
A: He is another young wing player for the Knicks who had been gaining attention for his recent performances.
Make sure you bookmark Knicks on SI for the latest news, exclusive interviews, film breakdowns and so much more!
Keep reading
- Biltmore Championship Asheville Power Rankings
- Juventus: Spalletti’s Last Chance Under Fire as Conte Loops
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
- New Details Emerge in Aldine Robbery and Shooting Case (archyde.com)